Cargando…

Imaging and clinical features of Castleman Disease

BACKGROUND: Castleman disease (CD) is a group of uncommon lymphoproliferative disorders that is easily confused with lymphoma or other solid tumors. The purpose of our study was to evaluate the imaging and clinical findings of CD, and thus improve the understanding and diagnosis of CD. METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shuang, Wan, Ying, Huang, Zixing, Song, Bin, Yu, Jianqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659281/
https://www.ncbi.nlm.nih.gov/pubmed/31345268
http://dx.doi.org/10.1186/s40644-019-0238-0
_version_ 1783439104456785920
author Zhao, Shuang
Wan, Ying
Huang, Zixing
Song, Bin
Yu, Jianqun
author_facet Zhao, Shuang
Wan, Ying
Huang, Zixing
Song, Bin
Yu, Jianqun
author_sort Zhao, Shuang
collection PubMed
description BACKGROUND: Castleman disease (CD) is a group of uncommon lymphoproliferative disorders that is easily confused with lymphoma or other solid tumors. The purpose of our study was to evaluate the imaging and clinical findings of CD, and thus improve the understanding and diagnosis of CD. METHODS: This retrospective study included 74 patients (37 men and 37 women, mean age ± standard deviation, 35 ± 15.2 years,) with histopathologically confirmed CD diagnosed based on CT or MRI between January 2010 and May 2017. The CT and MRI findings were analyzed by two radiologists in consensus, and clinical presentation and histopathologic characteristics were documented. RESULTS: The CD subtypes included 61 hyaline vascular variant cases (82.4%) and 13 plasma cell variant cases (17.6%). Unicentric CD and multicentric CD were observed in 65 (87.8%) and 9 (12.2%) patients, respectively. On non-enhanced CT, enlarged nodes with hypodensity or isodensity were seen, whereas varying degrees of enhancement were observed in contrast-enhanced CT. Homogeneous and heterogeneous enhancements were observed in 43 (62.3%) and 26 (37.7%) patients, respectively. Hypertrophied vessels and calcification were detected in 38 (51.2%) and 18 (24.3%) patients, respectively. MRI revealed hypointense to isointense lesions on T1-weighted images, isointense to hyperintense lesions on T2-weighted images, and hyperintense lesions on diffusion-weighted imaging; 9 (75%) and 3 (25%) patients demonstrated homogeneous and heterogeneous enhancement, respectively. CONCLUSION: CD often shows well-defined, mildly hypodense or isodense, homogeneous lymph nodules on non-enhanced CT/MRI, with intermediate and marked enhancement on contrast-enhanced CT/MRI. Calcification and hypertrophied vessels may be valuable diagnostic features.
format Online
Article
Text
id pubmed-6659281
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66592812019-08-01 Imaging and clinical features of Castleman Disease Zhao, Shuang Wan, Ying Huang, Zixing Song, Bin Yu, Jianqun Cancer Imaging Research Article BACKGROUND: Castleman disease (CD) is a group of uncommon lymphoproliferative disorders that is easily confused with lymphoma or other solid tumors. The purpose of our study was to evaluate the imaging and clinical findings of CD, and thus improve the understanding and diagnosis of CD. METHODS: This retrospective study included 74 patients (37 men and 37 women, mean age ± standard deviation, 35 ± 15.2 years,) with histopathologically confirmed CD diagnosed based on CT or MRI between January 2010 and May 2017. The CT and MRI findings were analyzed by two radiologists in consensus, and clinical presentation and histopathologic characteristics were documented. RESULTS: The CD subtypes included 61 hyaline vascular variant cases (82.4%) and 13 plasma cell variant cases (17.6%). Unicentric CD and multicentric CD were observed in 65 (87.8%) and 9 (12.2%) patients, respectively. On non-enhanced CT, enlarged nodes with hypodensity or isodensity were seen, whereas varying degrees of enhancement were observed in contrast-enhanced CT. Homogeneous and heterogeneous enhancements were observed in 43 (62.3%) and 26 (37.7%) patients, respectively. Hypertrophied vessels and calcification were detected in 38 (51.2%) and 18 (24.3%) patients, respectively. MRI revealed hypointense to isointense lesions on T1-weighted images, isointense to hyperintense lesions on T2-weighted images, and hyperintense lesions on diffusion-weighted imaging; 9 (75%) and 3 (25%) patients demonstrated homogeneous and heterogeneous enhancement, respectively. CONCLUSION: CD often shows well-defined, mildly hypodense or isodense, homogeneous lymph nodules on non-enhanced CT/MRI, with intermediate and marked enhancement on contrast-enhanced CT/MRI. Calcification and hypertrophied vessels may be valuable diagnostic features. BioMed Central 2019-07-25 /pmc/articles/PMC6659281/ /pubmed/31345268 http://dx.doi.org/10.1186/s40644-019-0238-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zhao, Shuang
Wan, Ying
Huang, Zixing
Song, Bin
Yu, Jianqun
Imaging and clinical features of Castleman Disease
title Imaging and clinical features of Castleman Disease
title_full Imaging and clinical features of Castleman Disease
title_fullStr Imaging and clinical features of Castleman Disease
title_full_unstemmed Imaging and clinical features of Castleman Disease
title_short Imaging and clinical features of Castleman Disease
title_sort imaging and clinical features of castleman disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659281/
https://www.ncbi.nlm.nih.gov/pubmed/31345268
http://dx.doi.org/10.1186/s40644-019-0238-0
work_keys_str_mv AT zhaoshuang imagingandclinicalfeaturesofcastlemandisease
AT wanying imagingandclinicalfeaturesofcastlemandisease
AT huangzixing imagingandclinicalfeaturesofcastlemandisease
AT songbin imagingandclinicalfeaturesofcastlemandisease
AT yujianqun imagingandclinicalfeaturesofcastlemandisease